# Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lenalidomide-and-dexamethasone-in-transplant-ineligible-patients-with-myeloma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lotfi Benboubker,Meletios Α. Dimopoulos,Angela Dispenzieri,John Catalano,Andrew R. Belch,Michèle Cavo,Antonello Pinto,Katja Weisel,Heinz Ludwig,Nizar J. Bahlis,Anne Banos,Mourad Tiab,Michel Delforge,Jamie Cavenagh,Catarina Geraldes,Je‐Jung Lee,Christine Chen,Albert Oriol,Javier de la Rubia,Lugui Qiu,Darrell White,Daniel Binder,Kenneth Anderson,Jean-Paul Fermand,Philippe Moreau,Michel Attal,Robert Knight,Guang Chen,Jason Van Oostendorp,Christian Jacques,Annette Ervin‐Haynes,Hervé Avet‐Loiseau,Cyrille Hulin,Thierry Façon |
| Citations | 790 |
| DOI | 10.1056/nejmoa1402551 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1402551?articleTools=true |
| OpenAlex ID | https://openalex.org/W2141105112 |
| PMID | 25184863 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Michel Delforge](https://scholariq.org/researchers/michel-delforge/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.